Table II.
Clinical features of the WI-FTC patients in this study.
| Distant metastasis
|
|||||||
|---|---|---|---|---|---|---|---|
| No. | Metastasis | Sex | Agea | Operation method | Period (month) | Location | Additional therapies |
| 35 | + | M | 43 | Lo | 23 | L | TT and RAT |
| 36 | + | F | 75 | TT | 0 | L, T | RAT |
| 37 | + | F | 76 | TT | 0 | L | RAT |
| 38 | + | F | 60 | TT | 101 | L | RAT |
| 39 | + | F | 56 | TT | 54 | B | RAT |
| 40 | + | F | 34 | TT | 39 | L | RAT |
| 41 | + | F | 42 | TT | 93 | L, B | RAT |
| 42 | + | F | 63 | Lo | 51 | L | TT and RAT |
| 43 | + | M | 63 | TT | 0 | L | RAT |
| 44 | + | F | 65 | TT | 15 | B | RAT |
| 45b | − | F | 39 | Lo | na | ||
| 46b | − | F | 37 | Lo | na | ||
| 47b | − | F | 36 | Lo | na | ||
F, female; M, male; TT, total thyroidectomy; Lo, right or left thyroid lobectomy; L, lung; B, bone; T, tumor embolism; RAT, radioiodine ablation therapy; na, not applicable.
a
Age: median 53.0 (range 34–76).
b
The patients in number 45–47 are followed up in post-operation within 2 years.